How Common Is Celiac Disease?

Is celiac disease more common than doctors think?

Yes. In a new pooled analysis of 87 screening studies covering 394,274 people, about 1 in 70 people worldwide tested positive for celiac disease antibodies, and about 1 in 120 had the diagnosis confirmed by biopsy. More than 4 in 10 of those confirmed cases had no symptoms at all.

Celiac disease is an immune reaction to gluten, a protein in wheat, barley, and rye. In people with the disease, eating gluten damages the lining of the small intestine, which is where you absorb nutrients. Diagnosis usually happens in two steps. First a blood test looks for antibodies, most often one called tTG-IgA. If that test is positive, a doctor takes a small tissue sample from the intestine to confirm the damage.

These researchers searched four medical databases through April 2024 for studies that screened general populations, not people who were already sick or already suspected of having celiac disease. That distinction matters. Screening a random slice of the public tells you how common a condition really is, rather than how often it gets diagnosed in clinic.

What the Data Show

Across all 87 studies, 1.5% of people were antibody-positive, a figure very likely to sit between 1.3% and 1.8% (95% CI 1.3 to 1.8). Biopsy-confirmed celiac disease came in at 0.8%, very likely between 0.6% and 1.0%. That works out to roughly 1 in 70 seropositive and 1 in 120 with confirmed disease.

The disease was not spread evenly. Prevalence was 50% higher in females than in males, and nearly double in children compared with adults. Geography mattered too. Antibody positivity was highest in Oceania and North America, while biopsy-confirmed disease was highest in Europe and South America. High-income countries showed the highest prevalence overall, which likely reflects both real differences and better access to testing.

Then there is the symptom question. Among people with biopsy-confirmed celiac disease, 41.4% had no symptoms. Another 30.8% of those who were biopsied met criteria for “potential” celiac disease, meaning their blood test was positive but their intestinal lining still looked normal.

Dr. Kumar’s Take

The symptom number matters most here. If 41.4% of confirmed cases feel fine, then the classic picture of celiac disease, a thin child with diarrhea and belly pain, describes a minority of people who actually have it. That is a strong argument that the condition is being missed on a large scale, and it is why celiac disease keeps getting called an iceberg.

The other finding with real teeth is that how you test changes what you find. Using more than one antibody test raised the positivity rate by 40%, from 1.5% to 2.1%. In people who are IgA deficient, meaning their body makes little of the antibody type the standard test looks for, adding a test called DGP-IgG raised the rate by 120%, up to 2.2%. A normal standard test in an IgA deficient person is close to meaningless, and that is a well-known gap that still slips through.

I would not read this as a case for screening every person on the planet. What it does support is a much lower threshold for testing when something does not add up: unexplained iron deficiency, low bone density, an autoimmune condition, a first-degree relative with celiac disease.

How Strong Is the Evidence?

This is a meta-analysis, which means it pools other people’s studies rather than running a new one. The pooled estimates carried very high heterogeneity, a statistical way of saying the individual studies disagreed with each other a great deal. Different countries, different age ranges, and different lab methods all push the numbers around, so the 1.5% and 0.8% figures are best read as a global center of gravity rather than a precise rate for any one place.

The design is still the right one for this question. These were general-population screening studies, so they avoid the bias you get from counting only the patients who walked into a gastroenterology clinic. And 394,274 participants is a large base to estimate from.

One number complicates all of it: 36.6% of people who tested antibody-positive never had a biopsy. Over a third of the positive results were never resolved either way. That leaves the true confirmed-disease figure with real room to move.

Why So Many Cases Stay Hidden

Put the pieces together and the detection gap is not one problem but three. A large share of people with celiac disease feel well, so nothing prompts a test. A single antibody test misses cases that a broader panel would catch, especially in people with IgA deficiency. And when a test does come back positive, more than a third of the time the workup stops there.

None of that means every bloated stomach is celiac disease. It means the people most likely to be missed are the ones who look healthy, and the only way to find them is to think of the diagnosis when the obvious symptoms are absent.

Practical Takeaways

If you have unexplained iron deficiency, low bone density, another autoimmune condition, or a parent, sibling, or child with celiac disease, ask your doctor whether celiac antibody testing makes sense for you.
Do not start a gluten-free diet before testing, because both the antibody blood test and the biopsy depend on you still eating gluten to show the reaction.
If your tTG-IgA test comes back negative, ask whether your total IgA level was checked, since a low IgA level can make that standard test look falsely normal.
If an antibody test comes back positive, follow it through to a confirming biopsy or a specialist referral rather than assuming the result speaks for itself.

FAQs

Should I get tested for celiac disease if I feel fine?

Routine screening of people with no symptoms and no risk factors is not standard practice anywhere, and this study does not change that. What it does change is the assumption that feeling fine rules the diagnosis out, since 41.4% of confirmed cases in this analysis were symptom-free. The people with the strongest case for testing despite feeling well are close relatives of someone with celiac disease, and people with type 1 diabetes, autoimmune thyroid disease, or unexplained lab abnormalities. Talk to your doctor about which of those applies to you.

What is “potential” celiac disease?

Among people who were biopsied in these studies, 30.8% met criteria for potential celiac disease. That means the antibody test was positive but the intestinal lining had not yet shown the damage that confirms the diagnosis. It is a real category, not a lab error, and it usually calls for follow-up over time rather than an immediate lifelong diet change. How often potential celiac disease progresses to full disease was not something this analysis set out to measure.

Why does celiac disease seem more common in women and children?

This analysis found prevalence 50% higher in females and nearly double in children, but a prevalence study can show a pattern without explaining it. Autoimmune conditions in general run higher in women, so the sex difference fits a broader pattern. The child finding is harder to interpret, since some children who test positive early may not have persistent disease, and screening studies in schools tend to be thorough in a way that adult studies often are not. Both patterns are worth knowing when deciding whether to test, and neither is a reason to skip testing in an adult man.

Bottom Line

Pooling 87 general-population screening studies and 394,274 people, this meta-analysis puts celiac disease antibodies in about 1 in 70 people worldwide and biopsy-confirmed celiac disease in about 1 in 120. The most useful finding is not the headline rate but the shape of what is being missed: 41.4% of confirmed cases had no symptoms, 36.6% of positive blood tests were never followed by a biopsy, and broader antibody panels found substantially more cases than a single test did. The diagnosis is common, symptomless in a large minority of people, and easier to find than current practice suggests.

Read the full study